Siri Tahtinen

Genentech, Inc - South San Francisco / United States

Medical and Health Sciences / Immunology

AD Scientific Index ID: 4426739

-

Registration, Add Profile,
Premium Membership

Print Your Certificate

Siri Tahtinen's MOST POPULAR ARTICLES

1-) IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccinesS Tahtinen, AJ Tong, P Himmels, J Oh, A Paler-Martinez, L Kim, ...Nature immunology 23 (4), 532-542, 20222492022

2-) Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenovirusesK Watanabe, Y Luo, T Da, S Guedan, M Ruella, J Scholler, B Keith, ...JCI insight 3 (7), 20182432018

3-) Antiviral and antitumor T-cell immunity in patients treated with GM-CSF–coding oncolytic adenovirusA Kanerva, P Nokisalmi, I Diaconu, A Koski, V Cerullo, I Liikanen, ...Clinical Cancer Research 19 (10), 2734-2744, 20132032013

4-) Artificially cloaked viral nanovaccine for cancer immunotherapyM Fusciello, F Fontana, S Tähtinen, C Capasso, S Feola, B Martins, ...Nature communications 10 (1), 5747, 20191282019

5-) Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable successful adoptive cell therapyR Havunen, M Siurala, S Sorsa, S Grönberg-Vähä-Koskela, M Behr, ...Molecular Therapy-Oncolytics 4, 77-86, 20171232017

ARTICLES

Add your articles